Evaxion Biotech A/S
EVAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11 | -$22 | -$23 | -$25 |
| Dep. & Amort. | $1 | $1 | $1 | $0 |
| Deferred Tax | -$1 | -$1 | -$1 | -$0 |
| Stock-Based Comp. | $0 | $0 | $1 | $1 |
| Change in WC | $1 | $2 | -$3 | $1 |
| Other Non-Cash | -$3 | $3 | -$0 | -$0 |
| Operating Cash Flow | -$13 | -$18 | -$26 | -$22 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$0 | -$0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$0 | -$0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | $7 | -$0 |
| Stock Issued | $17 | $9 | $0 | $54 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $2 | $0 | -$4 |
| Financing Cash Flow | $13 | $11 | $8 | $50 |
| Forex Effect | $0 | -$1 | -$1 | -$0 |
| Net Chg. in Cash | $0 | -$8 | -$19 | $26 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6 | $13 | $32 | $6 |
| End Cash | $6 | $6 | $13 | $32 |
| Free Cash Flow | -$13 | -$18 | -$26 | -$23 |